Schultz lists the reasons in Boomtown USA. I don't have the space here to spoil Schultz's story.

FORBES: Tiny Titans

Schultz will continue to serve warmed pastries--don't tell us those have less odor.

FORBES: Magazine Article

Daniel Schultz, the FDA's chief device regulator, says new medical devices don't need the large-scale exhaustive trials of the drug industry because it is easier to predict the behavior of a machine than it is to track the chemical interactions of a new drug in the body.

FORBES: On The Cover/Top Stories